retatrutide type 2 diabetes trial 2024 Effects of on body composition in people with diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised New Kind of Diabetes Drug

The most commonly reported side effects during the first month are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, consistent with other GLP-1-containing therapies

So on GLP-1 peptides, think: Smaller portions overall, but every bite works harder for me , more fiber, more protein, fewer empty carbs. GLP-1Friendly Plate Blueprint When you sit down to eat during Nuris Body Recomposition Program featuring Retatrutide, use this simple mental checklist: Start with protein (the anchor of the meal)

Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials

Benefits of Weight Loss for the Heart Reduced strain on the heart muscle Lower systolic and diastolic blood pressure Improved cholesterol profiles (increased HDL, decreased LDL and triglycerides) Reduced risk of heart disease and stroke How GLP-1 Medications Support More Than Weight Loss GLP-1 receptor agonists such as semaglutide and tirzepatide were originally developed to support blood sugar control

Weight loss in week 1 is usually minimal (1-3 pounds, often water)